The United States represents a major contributor to the Stomach Cancer Therapeutics Market, supported by advanced healthcare infrastructure, strong oncology research capabilities, and widespread adoption of innovative cancer therapies. The country benefits from significant investments in clinical research, the presence of leading pharmaceutical companies, and increasing utilization of precision...